Session 405 - Crystallization of Pharmaceutical and Biological Molecules I


Pharmaceuticals
Session 405 - Crystallization of Pharmaceutical and Biological Molecules I
This session welcomes papers addressing fundamental as well as applied studies in the area of crystallization of pharmaceutical or biological molecules. Topics related to experimental studies, theory and simulation that contribute to fundamental understanding of crystallization as well as industrial case studies on the crystallization development of pharmaceutical and biological compounds are encouraged.
Chair:	Constance Schall
CoChair:	Bing-Shiou Yang
CoSponsor(s):	Crystallization and Evaporation
	405a	Application of Pharmaceutical Solvates In Drug Development Yanfeng Zhang, Yaling Wang, Louis S. Crocker
	405b	Phase Diagram Visualization Via Continuously-Fed Crystallization: Experiments and Model Masano Sugiyama, Victor H. Barocas
	405c	Separation and Purification of (âˆ’)Schisandrin B from Schisandrin B Stereoisomers Ka F. Luk, Robert Kam M. Ko, Ka M. Ng
	405d	Solvent Effects on the Molecular Self-Assembly of Tetrolic Acid In Solution and Its Implications of the Polymorph Formed from Crystallization Jie ChEn, Bernhardt L. Trout
	Â	Break
	405e	Biological Macromolecule Crystallization for Structure Based Drug Design: Finding the Keys for Crystallization Success Russell A. Judge
	405f	Protein Crystallization: Studies with Gamma D-Crystallin, a Protein Involved In Cataract Formation Quinta Nwanosike, Athanassios Sambanis, Ronald W. Rousseau
	405g	Monoclonal Antibody Interactions and Phase Behavior Rachael A. Lewus, Abraham M. Lenhoff, Stanley I. Sandler

See more of Food, Pharmaceutical & Bioengineering Division

See more of The 2008 Annual Meeting

Pharmaceuticals